June 20 (Reuters) - Private equity firm Pamplona Capital Management is nearing a deal to buy contract drug research firm Parexel International Corp for $4.6 billion, the Wall Street Journal reported on Tuesday.
Pamplona is set to pay $88.10 a share in cash as part of the deal, the newspaper said citing people familiar with the matter. (on.wsj.com/2slumT7)
Parexel was not immediately available to comment outside regular U.S. business hours.
Reporting by Subrat Patnaik in Bengaluru; Editing by Amrutha Gayathri